CN Patent

CN111971044A — 米加司他用于治疗妊娠患者的法布里病的用途

Assigned to Amicus Therapeutics Inc · Expires 2020-11-20 · 5y expired

What this patent protects

提供治疗被诊断患有法布里病的患者的方法。某些方法用治疗有效剂量的米加司他或其盐治疗妊娠患者。其他方法用治疗有效剂量的米加司他或其盐治疗有生育能力的患者。还描述了妊娠的成功结果，在所述妊娠期间用米加司他治疗妊娠患者。

USPTO Abstract

提供治疗被诊断患有法布里病的患者的方法。某些方法用治疗有效剂量的米加司他或其盐治疗妊娠患者。其他方法用治疗有效剂量的米加司他或其盐治疗有生育能力的患者。还描述了妊娠的成功结果，在所述妊娠期间用米加司他治疗妊娠患者。

Drugs covered by this patent

Patent Metadata

Patent number
CN111971044A
Jurisdiction
CN
Classification
—
Expires
2020-11-20
Drug substance claim
No
Drug product claim
No
Assignee
Amicus Therapeutics Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.